Detalhe da pesquisa
1.
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
N Engl J Med
; 388(16): 1478-1490, 2023 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36877098
2.
Sotatercept for the Treatment of Pulmonary Arterial Hypertension.
N Engl J Med
; 384(13): 1204-1215, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789009
3.
Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension.
Circulation
; 146(14): 1033-1045, 2022 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36004627
4.
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension.
Eur Respir J
; 61(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041750
5.
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial.
Eur Respir J
; 62(3)2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696565
6.
Vascular smooth muscle ROCK1 contributes to hypoxia-induced pulmonary hypertension development in mice.
Biochem Biophys Res Commun
; 604: 137-143, 2022 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303680
7.
Temporarily switching from oral to intravenous selexipag in patients with pulmonary arterial hypertension: safety, tolerability, and pharmacokinetic results from an open-label, phase III study.
Respir Res
; 22(1): 34, 2021 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33536021
8.
Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling.
FASEB J
; 34(1): 930-944, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914588
9.
Risk stratification and medical therapy of pulmonary arterial hypertension.
Eur Respir J
; 53(1)2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545971
10.
Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension.
Eur Respir J
; 51(6)2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29954925
11.
Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension.
Am J Physiol Lung Cell Mol Physiol
; 313(5): L752-L762, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28775095
12.
Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men.
Am J Respir Crit Care Med
; 193(10): 1168-75, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26651504
13.
Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).
Circulation
; 132(25): 2403-11, 2015 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26510696
14.
Chronic Thromboembolic Pulmonary Hypertension: Experience from a Single Center in Mexico.
Lung
; 194(2): 315-23, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26748498
15.
An Event-driven Trial for Oral Treprostinil. Progress but Not the Holy Grail.
Am J Respir Crit Care Med
; 201(6): 647-649, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31904994
16.
Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.
Am J Respir Crit Care Med
; 198(2): 166-174, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29425462
17.
[Updated treatment algorithm of pulmonary arterial hypertension]. / Pulmoner arter hipertansiyonunun güncel tedavi algoritmasi.
Turk Kardiyol Dern Ars
; 42 Suppl 1: 78-94, 2014 Oct.
Artigo
em Turco
| MEDLINE | ID: mdl-25697036
18.
Two prospective, multicenter studies for the identification of biomarker signatures for early detection of pulmonary hypertension (PH): The CIPHER and CIPHER-MRI studies.
Pulm Circ
; 14(2): e12386, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38868397
19.
Lung-specific interleukin 6 mediated transglutaminase 2 activation and cardiopulmonary fibrogenesis.
Front Immunol
; 15: 1371706, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650935
20.
Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension.
Am J Physiol Lung Cell Mol Physiol
; 304(10): L678-88, 2013 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23457185